FOXO4-DRI F410 10mg*10vials

F410 10mg*10 vials belongs to the CN Peptide Anti-Aging and Longevity Series. FOXO4-DRI is a cell-penetrating peptide designed to interfere with the FOXO4-p53 protein interaction associated with the survival of senescent cells. This research-grade peptide is produced using solid-phase peptide synthesis and lyophilized under strict aseptic conditions, resulting in high purity, low endotoxin, and reliable chemical stability. Each vial contains 10mg of lyophilized powder, and each box contains 10 vials. It is a key tool for preclinical research, used to study senescent cell clearance, cellular senescence mechanisms, and longevity-related biological pathways.

Product Functions and Research Value

F410 FOXO4-DRI provides four core research uses for aging-related laboratory work: interfering with the FOXO4-p53 molecular complex to modulate survival signals in senescent cells; supporting in vitro and preclinical studies of senescent cell clearance mechanisms; facilitating the exploration of phenotypic changes following senescent cell regulation; and providing standardized peptide material for studying age-related changes in the tissue microenvironment. The accumulation of senescent cells is closely related to tissue aging and age-related functional decline. FOXO4-DRI allows for controlled perturbation of aging-related signaling pathways, helping researchers obtain reproducible experimental data to explore mechanisms of senescent cell clearance and longevity.

Core Product Advantages

1. Targeted Aging-Related Peptides: Engineered to interfere with FOXO4-p53 interactions, suitable for studies on senescent cell clearance and cellular senescence.

2. High-Quality Lyophilized Peptides: The lyophilized form, synthesized in a solid phase, improves long-term storage stability and reduces the risk of molecular degradation.

3. Low Endotoxin, Research Grade: Rigorous purification processes minimize endotoxin contamination and reduce non-specific experimental background noise.

4. Good Solubility: Easy to reconstitute using compatible peptide solvents, suitable for cellular or preclinical assays.

5. Strict Batch Quality Control: Each batch undergoes high-performance liquid chromatography (HPLC) purity testing and endotoxin and physicochemical property verification.

6. Practical Packaging: 10 mg per vial, 10 vials per box, suitable for routine laboratory research and bulk project procurement.

F410 10mg*10 vials, a FOXO4-DRI research peptide from a Chinese anti-aging and longevity series. A targeted peptide used to study the FOXO4-p53 signaling pathway, regulation of senescent cells, and mechanisms of cellular senescence. High-purity lyophilized powder, low endotoxin, verified by high-performance liquid chromatography. Wholesale available.